Brief: PCI Biotech Granted New US Patent

PCI Biotech Holding ASA

31/05/2021 10:23

May 31 (Reuters) - PCI Biotech Holding ASA  PCIB.OL :
    * TODAY ANNOUNCES THAT U.S. PATENT AND TRADEMARK OFFICE
(USPTO)
HAS INFORMED COMPANY THAT A NEW US PATENT WILL BE GRANTED EARLY
JUNE 2021.
    * US PATENT COVERS USE OF FIMAVACC IN COMBINATION WITH
IMMUNE
CHECKPOINT INHIBITORS (ICIS)
    * TODAY'S ANNOUNCED US PATENT SECURE PROTECTION UNTIL 2036
AND
THIS PATENT APPLICATION IS STILL PENDING IN EUROPE AND KEY ASIAN
MARKETS.

Source text for Eikon:  ID:nGNEbdsfwR 
Further company coverage:  PCIB.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))